Advertisement
ProteinSimple
ProteinSimple

The Scientist

» drug development

Most Recent

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Loss of Microtubule Regulator Blocks Sperm Maturation

Loss of Microtubule Regulator Blocks Sperm Maturation

By | May 24, 2012

New research suggests that controlling cytoskeletal dynamics in sperm accessory cells may help regulate male fertility.

0 Comments

image: US Drug Approvals Top Canada, Europe

US Drug Approvals Top Canada, Europe

By | May 18, 2012

The FDA approves drugs faster and earlier than regulatory agencies in other countries.

3 Comments

image: FDA Eases Sterility Requirements

FDA Eases Sterility Requirements

By | May 16, 2012

The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.

1 Comment

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: New Target for Aspirin

New Target for Aspirin

By | April 20, 2012

New work on salicylate, a natural component of aspirin, suggests that activation of the energy-sensing AMP kinase may underlie some of aspirin’s health benefits.

6 Comments

image: An Antidote for Cocaine Overdose?

An Antidote for Cocaine Overdose?

By | April 19, 2012

A novel antibody with a powerful affinity for cocaine shows promise in reversing the deadly effects of an overdose.

2 Comments

image: Repurpose Failed Drugs, NIH Urges

Repurpose Failed Drugs, NIH Urges

By | April 16, 2012

Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement